Financial Data and Key Metrics Changes - For the first three quarters of 2025, total revenue reached CNY 2.57 billion, a year-on-year increase of 23.1, while net profit attributable to ordinary shareholders was approximately CNY 410 million, rising 51.9% compared to the same period last year [1] - In Q3, total revenue was CNY 975 million, marking a year-on-year growth of 38.4, with operating profit nearly CNY 114 million, a substantial year-on-year increase of 329.8% [21][24] - Net profit attributable to ordinary shareholders in Q3 reached CNY 158 million, up 60.1% year-on-year [24] Business Segment Data and Key Metrics Changes - The insurtech business generated an operating profit of about CNY 180 million in Q3, a year-on-year increase of 44.3% [1] - Insurance-related revenue reached about CNY 870 million, increasing by 44.8% year-on-year and 17.8% quarter-on-quarter [7] - Profiling service fees stood at around CNY 65.66 million, remaining stable year-on-year, while digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [22] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 [2] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [2][17] - The eFind platform extended its collaboration network by partnering with 216 pharmaceutical and contract research organizations [17] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, fueling sustainable long-term growth [5] - Waterdrop C-Point AI was launched as a low-code AI platform to empower employees in building tailored solutions for various tasks [3] - The company is exploring applications of AI in non-insurance areas to support growth [3] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in exceeding full-year revenue and profit guidance, supported by robust business performance [5] - The company emphasized the importance of refined management while achieving scale growth [25] - Management highlighted the ongoing investment in AI and its impact on operational efficiency and decision-making [12][13] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, approximately 58.1 million ADS had been repurchased in the open market, totaling $113 million [5] - The company updated its ESG measures and released the 2024 annual ESG report, enhancing its governance framework [4] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][17] - Operating profit for the insurtech business reached about CNY 180 million, a year-on-year increase of 44.3% [3][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][20] - WaterDrop C-Point AI, a low-code AI platform, was launched to enhance operational efficiency and support various business tasks [4][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company is committed to sustainable development and creating value for society through its initiatives [5] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - As of the end of September, the company held a cash position of about CNY 3.61 billion, ensuring financial support for business expansion [19] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% year-on-year increase [2] Business Line Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Operating profit for the insurtech segment reached approximately CNY 180 million, marking a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [15][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring AI applications in non-insurance areas to support growth [4] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company has maintained GAAP profitability for 15 consecutive quarters since Q1 2022 [3] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million [5] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - The company reported total revenue of CNY 975 million for Q3 2025, reflecting a year-on-year growth of 38.4% [2][16] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][18] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [6][16] - Operating profit for the insurtech segment reached approximately CNY 180 million, a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][16] Market Data and Key Metrics Changes - The medical profiling platform raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][12] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][18] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring applications of AI in non-insurance areas to support growth [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, supported by strong business performance [6] - The company emphasized the importance of AI in enhancing operational efficiency and decision-making capabilities [8][10] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, approximately 58.1 million ADS were repurchased in the open market, totaling $113 million [5] Q&A Session Summary Question: What are the expectations for future growth in the insurance business? - Management highlighted significant growth momentum in the insurance business, with a focus on optimizing real-time identification capabilities and enhancing product offerings [6][7] Question: How is the company addressing operational efficiency? - The company is deploying AI widely across operations, which has led to improved response times and increased productivity in various service scenarios [10][17]

Financial Data and Key Metrics Changes - For the first three quarters of 2025, total revenue reached CNY 2.57 billion, a year-on-year increase of 23.1, while net profit attributable to ordinary shareholders was approximately CNY 410 million, rising 51.9% compared to the same period last year [1] - The company reported total revenue of CNY 975 million for the third quarter, marking a year-on-year growth of 38.4 [13] - Operating profit for the quarter was nearly CNY 114 million, reflecting a substantial year-over-year increase of 329.8%, with net profit attributable to ordinary shareholders reaching CNY 158 million, up 60.1% year-over-year [15] Business Line Data and Key Metrics Changes - The insurtech business achieved an operating profit of about CNY 180 million in the quarter, a year-on-year increase of 44.3% [1] - Insurance-related revenue reached approximately CNY 870 million, increasing by 44.8% year-on-year and 17.8% quarter-on-quarter, with an operating profit margin of 20.3% [4] - Profiling service fees stood at around CNY 65.66 million, remaining stable year-on-year, while digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [14] Market Data and Key Metrics Changes - As of September 30, 2025, the cumulative registrations for the medical profiling platform reached approximately 485 million, with a total of CNY 71.2 billion raised for 3.61 million patients [9] - The digital clinical trial solution income in the third quarter reached CNY 31.85 million, marking a 31.3% year-on-year increase [12] Company Strategy and Development Direction - The company is focused on leveraging advancing AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [4] - The launch of Waterdrop C-Point AI, a low-code AI platform, is intended to empower employees to build and deploy tailored solutions for various tasks, supporting growth in both insurance and non-insurance areas [2] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in exceeding full-year revenue and profit guidance, emphasizing the importance of AI in enhancing operational efficiency and decision-making [4] - The company highlighted its commitment to sustainable development and creating value for society through its various initiatives [2] Other Important Information - The company has filed 69 patent applications centered on large language models, including nine international filings, indicating a strong focus on innovation [2] - As of the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million [3] Q&A Session Summary Question: What are the key drivers of growth in the insurance business? - The insurance business maintained significant growth momentum, with optimized real-time identification capabilities and enhanced integration of data links among advertising, operation, and risk control systems [4] Question: How is the company addressing operational efficiency? - The deployment of AI across various services has significantly improved operational efficiency, with AI medical insurance experts boosting productivity and response times [7][8]